The researchers identified proteins that the starfish emit when aggregating to reproduce, and could be used to create synthetic chemicals to help capture and eradicate the pest.
The proceeds will be used to advance the firm's CropOS computational platform, and to develop other promising product candidates for increasing crop yields.
The chemical conglomerate is the second firm to license CRISPR/Cas9 from the Broad after Monsanto.
The clinical genetics and genomics testing firm said the funding will help as it seeks to consolidate its presence in international markets.
The company said the funds would be used to develop new products based on its proprietary mass spec technology.
The company said it will use the proceeds to support the development of a prototype pathogen detection platform.
The company will provide DNA analysis services to a Norwegian salmon breeding consortium.
Researchers sequenced the mitochondrial genomes of two ancient bison and compared them to other bison samples, and found two waves of bison dispersal.
The company has developed a suite of initial products focused on ancestry that will compete with offerings from 23andMe, AncestryDNA, and Family Tree DNA.
The company said it had 53 of its Atlas molecular diagnostic systems placed with customers under commercial agreements as of the end of 2016.
The Seattle-based firm plans to partner with pharma and biotech to use its duplex sequencing technology in applications such as oncology and forensics.
The developers said such a signature could help triage people exposed to radiation through war, a terrorist attack, or an industrial accident.
Hygiena will sell DuPont Diagnostics products through its Qualicon Diagnostics unit.
The researchers plan to commercialize the method, which they said can have applications in both forensics and oncology.
The genome of the mite provides insight into the parasite's biology, which could identify gene-based strategies to control future infestations.
The company sells the portable Hunter Real-Time PCR instrument for DNA analysis and a portfolio of test kits for use in food safety, food fraud, and microbiologically influenced corrosion.
The proceeds from the seed round will enable the company to fund the development and commercial launch of a $15 genomic test for dairy and beef cattle.
The Thermo Fisher subsidiary is not liable to Promega in the US for selling infringing forensic DNA kits in Europe, containing US-manufactured Taq polymerase.
The funding is being provided through the Massachusetts Life Sciences Center, which oversees the state's $1 billion life sciences investment plan.
IDT has licensed the CRISPR/Cpf1 RNA-guided editing system from the Broad Institute and intends to sell it to pharmaceutical and other commercial labs.
The president of France's National Research Agency has resigned, according to Nature News.
A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.
In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.
The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.